Authors:
O'Day, SJ
Boasberg, PD
Kristedja, TS
Martin, M
Wang, HJ
Fournier, P
Cabot, M
DeGregorio, MW
Gammon, G
Citation: Sj. O'Day et al., High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma, CANCER, 92(3), 2001, pp. 609-619
Authors:
Hellmann-Blumberg, U
Taras, TL
Wurz, GT
DeGregorio, MW
Citation: U. Hellmann-blumberg et al., Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene, BREAST CANC, 60(1), 2000, pp. 63-70
Citation: Mw. Degregorio et al., Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selectiveestrogen-receptor modulator, EUR J CL PH, 56(6-7), 2000, pp. 469-475
Citation: Mw. Degregorio, Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 onendometrial cancer growth, J NAT CANC, 91(5), 1999, pp. 474-474
Authors:
Taras, TL
Wurz, GT
Hellmann-Blumberg, U
DeGregorio, MW
Citation: Tl. Taras et al., Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography, J CHROMAT B, 724(1), 1999, pp. 163-171